{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:43:01Z","timestamp":1759797781685,"version":"build-2065373602"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873919"],"award-info":[{"award-number":["81873919"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2021CFB442"],"award-info":[{"award-number":["2021CFB442"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Magn Reson Mater Phy"],"DOI":"10.1007\/s10334-025-01241-7","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T08:35:30Z","timestamp":1742200530000},"page":"781-790","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Using intra-voxel incoherent motion MRI to dynamically evaluate the attenuating effects of donafenib combined with carvedilol in a thioacetamide-induced hepatic fibrosis rat model"],"prefix":"10.1007","volume":"38","author":[{"given":"Jiacheng","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2360-1445","authenticated-orcid":false,"given":"Yaowei","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binqian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuansheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"issue":"10308","key":"1241_CR1","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","volume":"398","author":"P Gin\u00e8s","year":"2021","unstructured":"Gin\u00e8s P, Krag A, Abraldes JG, Sol\u00e0 E, Fabrellas N, Kamath PS (2021) Liver cirrhosis. Lancet 398(10308):1359\u20131376","journal-title":"Lancet"},{"key":"1241_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108445","volume":"689","author":"E Novo","year":"2020","unstructured":"Novo E, Bocca C, Foglia B, Protopapa F, Maggiora M, Parola M et al (2020) Liver fibrogenesis: un update on established and emerging basic concepts. Arch Biochem Biophys 689:108445","journal-title":"Arch Biochem Biophys"},{"issue":"10159","key":"1241_CR3","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","volume":"392","author":"GBD 2017 Causes of Death Collaborators","year":"2018","unstructured":"GBD 2017 Causes of Death Collaborators (2018) Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159):1736\u20131788","journal-title":"Lancet"},{"key":"1241_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","volume":"12","author":"AA Mokdad","year":"2014","unstructured":"Mokdad AA, Lopez AD, Shahraz S, Lozano R, Mokdad AH, Stanaway J et al (2014) Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med 12:145","journal-title":"BMC Med"},{"issue":"5","key":"1241_CR5","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/his.12070","volume":"62","author":"A Rastogi","year":"2013","unstructured":"Rastogi A, Maiwall R, Bihari C, Ahuja A, Kumar A, Singh T et al (2013) Cirrhosis histology and Laennec staging system correlate with high portal pressure. Histopathology 62(5):731\u2013741","journal-title":"Histopathology"},{"issue":"4","key":"1241_CR6","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/hep.24805","volume":"55","author":"S Sethasine","year":"2012","unstructured":"Sethasine S, Jain D, Groszmann RJ, Garcia-Tsao G (2012) Quantitative histological-hemodynamic correlations in cirrhosis. Hepatology 55(4):1146\u20131153","journal-title":"Hepatology"},{"issue":"4","key":"1241_CR7","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s12072-015-9648-7","volume":"9","author":"W Wang","year":"2015","unstructured":"Wang W, Li J, Pan R, Sileng A, Liao C (2015) Association of the Laennec staging system with degree of cirrhosis, clinical stage and liver function. Hepatol Int 9(4):621\u2013626","journal-title":"Hepatol Int"},{"issue":"8","key":"1241_CR8","doi-asserted-by":"publisher","first-page":"4227","DOI":"10.1245\/s10434-020-09557-5","volume":"28","author":"J Gu","year":"2021","unstructured":"Gu J, Zhang E, Liang B, Zhang Z, Chen X, Xiong M et al (2021) Liver Collagen Contents Are Closely Associated with the Severity of Cirrhosis and Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma and Child-Pugh Grade A Liver Function. Ann Surg Oncol 28(8):4227\u20134235","journal-title":"Ann Surg Oncol"},{"issue":"11\u201312","key":"1241_CR9","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1111\/apt.16111","volume":"52","author":"M Israelsen","year":"2020","unstructured":"Israelsen M, Guerrero Misas M, Koutsoumourakis A, Huang Y, Thiele M, Hall A et al (2020) Collagen proportionate area predicts clinical outcomes in patients with alcohol-related liver disease. Aliment Pharmacol Ther 52(11\u201312):1728\u20131739","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"1241_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1148\/radiol.13122506","volume":"270","author":"I Joo","year":"2014","unstructured":"Joo I, Lee JM, Yoon JH, Jang JJ, Han JK, Choi BI (2014) Nonalcoholic fatty liver disease: intravoxel incoherent motion diffusion-weighted MR imaging-an experimental study in a rabbit model. Radiology 270(1):131\u2013140","journal-title":"Radiology"},{"issue":"2","key":"1241_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/jmri.24796","volume":"42","author":"G Hu","year":"2015","unstructured":"Hu G, Chan Q, Quan X, Zhang X, Li Y, Zhong X et al (2015) Intravoxel incoherent motion MRI evaluation for the staging of liver fibrosis in a rat model. J Magn Reson Imaging 42(2):331\u2013339","journal-title":"J Magn Reson Imaging"},{"issue":"33","key":"1241_CR12","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.3748\/wjg.v24.i33.3738","volume":"24","author":"DV Garbuzenko","year":"2018","unstructured":"Garbuzenko DV, Arefyev NO, Kazachkov EL (2018) Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectives. World J Gastroenterol 24(33):3738\u20133748","journal-title":"World J Gastroenterol"},{"issue":"4","key":"1241_CR13","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/hep.22758","volume":"49","author":"M Mejias","year":"2009","unstructured":"Mejias M, Garcia-Pras E, Tiani C, Miquel R, Bosch J, Fernandez M (2009) Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats. Hepatology 49(4):1245\u20131256","journal-title":"Hepatology"},{"issue":"1","key":"1241_CR14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jhep.2010.02.027","volume":"53","author":"Y Wang","year":"2010","unstructured":"Wang Y, Gao J, Zhang D, Zhang J, Ma J, Jiang H (2010) New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. J Hepatol 53(1):132\u2013144","journal-title":"J Hepatol"},{"issue":"5","key":"1241_CR15","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1002\/hep.24254","volume":"53","author":"YL Chen","year":"2011","unstructured":"Chen YL, Lv J, Ye XL, Sun MY, Xu Q, Liu CH et al (2011) Sorafenib inhibits transforming growth factor \u03b21-mediated epithelial-mesenchymal transition and apoptosis in mouse hepatocytes. Hepatology 53(5):1708\u20131718","journal-title":"Hepatology"},{"key":"1241_CR16","first-page":"JCO2100163","volume":"29","author":"S Qin","year":"2021","unstructured":"Qin S, Bi F, Gu S, Bai Y, Chen Z, Wang Z et al (2021) Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial. J Clin Oncol 29:JCO2100163","journal-title":"J Clin Oncol"},{"issue":"2","key":"1241_CR17","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11030-018-9875-7","volume":"23","author":"L Zhong","year":"2019","unstructured":"Zhong L, Hou C, Zhang L, Zhao J, Li F, Li W (2019) Synthesis of deuterium-enriched sorafenib derivatives and evaluation of their biological activities. Mol Divers 23(2):341\u2013350","journal-title":"Mol Divers"},{"issue":"3","key":"1241_CR18","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.taap.2012.04.012","volume":"261","author":"N Hamdy","year":"2012","unstructured":"Hamdy N, El-Demerdash E (2012) New therapeutic aspect for carvedilol: antifibrotic effects of carvedilol in chronic carbon tetrachloride-induced liver damage. Toxicol Appl Pharmacol 261(3):292\u2013299","journal-title":"Toxicol Appl Pharmacol"},{"issue":"5","key":"1241_CR19","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.bbadis.2018.07.018","volume":"1865","author":"P K\u00f6nigshofer","year":"2019","unstructured":"K\u00f6nigshofer P, Brusilovskaya K, Schwabl P, Reiberger T (2019) Animal models of portal hypertension. Biochim Biophys Acta Mol Basis Dis 1865(5):1019\u20131030","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"2","key":"1241_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1148\/radiology.168.2.3393671","volume":"168","author":"D Le Bihan","year":"1988","unstructured":"Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168(2):497\u2013505","journal-title":"Radiology"},{"issue":"2","key":"1241_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1148\/radiology.177.2.2217777","volume":"177","author":"R Turner","year":"1990","unstructured":"Turner R, Le Bihan D, Maier J, Vavrek R, Hedges LK, Pekar J (1990) Echo-planar imaging of intravoxel incoherent motion. Radiology 177(2):407\u2013414","journal-title":"Radiology"},{"issue":"9055","key":"1241_CR22","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","volume":"349","author":"T Poynard","year":"1997","unstructured":"Poynard T, Bedossa P, Opolon P (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349(9055):825\u2013832","journal-title":"Lancet"},{"issue":"8","key":"1241_CR23","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1111\/jcmm.16363","volume":"25","author":"H Ogawa","year":"2021","unstructured":"Ogawa H, Kaji K, Nishimura N, Takagi H, Ishida K, Takaya H et al (2021) Lenvatinib prevents liver fibrosis by inhibiting hepatic stellate cell activation and sinusoidal capillarization in experimental liver fibrosis. J Cell Mol Med 25(8):4001\u20134013","journal-title":"J Cell Mol Med"},{"key":"1241_CR24","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.2147\/DDDT.S210797","volume":"13","author":"Y Wu","year":"2019","unstructured":"Wu Y, Li Z, Xiu AY, Meng DX, Wang SN, Zhang CQ (2019) Carvedilol attenuates carbon tetrachloride-induced liver fibrosis and hepatic sinusoidal capillarization in mice. Drug Des Devel Ther 13:2667\u20132676","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"1241_CR25","first-page":"1605","volume":"20","author":"L Ling","year":"2019","unstructured":"Ling L, Li G, Wang G, Meng D, Li Z, Zhang C (2019) Carvedilol improves liver cirrhosis in rats by inhibiting hepatic stellate cell activation, proliferation, invasion and collagen synthesis. Mol Med Rep 20(2):1605\u20131612","journal-title":"Mol Med Rep"},{"issue":"1","key":"1241_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/jmri.23607","volume":"36","author":"AM Chow","year":"2012","unstructured":"Chow AM, Gao DS, Fan SJ, Qiao Z, Lee FY, Yang J et al (2012) Liver fibrosis: an intravoxel incoherent motion (IVIM) study. J Magn Reson Imaging 36(1):159\u2013167","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"1241_CR27","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/jmri.24760","volume":"42","author":"S Ichikawa","year":"2015","unstructured":"Ichikawa S, Motosugi U, Morisaka H, Sano K, Ichikawa T, Enomoto N et al (2015) MRI-based staging of hepatic fibrosis: Comparison of intravoxel incoherent motion diffusion-weighted imaging with magnetic resonance elastography. J Magn Reson Imaging 42(1):204\u2013210","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"1241_CR28","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/hep.22742","volume":"49","author":"DC Rockey","year":"2009","unstructured":"Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD (2009) American Association for the Study of Liver Diseases. Liver biopsy Hepatology 49(3):1017\u20131044","journal-title":"Liver biopsy Hepatology"},{"issue":"8","key":"1241_CR29","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1136\/gutjnl-2020-321299","volume":"69","author":"J Neuberger","year":"2020","unstructured":"Neuberger J, Patel J, Caldwell H, Davies S, Hebditch V, Hollywood C et al (2020) Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology. Gut 69(8):1382\u20131403","journal-title":"Gut"},{"key":"1241_CR30","doi-asserted-by":"crossref","unstructured":"Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. SHARP Investigators Study Group. (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 359(4):378\u201390.","DOI":"10.1056\/NEJMoa0708857"},{"issue":"2","key":"1241_CR31","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3892\/or.2020.7870","volume":"45","author":"D Zhao","year":"2021","unstructured":"Zhao D, Chen J, Long X, Wang J (2021) Dose adjustment for tyrosine kinase inhibitors in non-small cell lung cancer patients with hepatic or renal function impairment (Review). Oncol Rep 45(2):413\u2013426","journal-title":"Oncol Rep"}],"container-title":["Magnetic Resonance Materials in Physics, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10334-025-01241-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10334-025-01241-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10334-025-01241-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T14:02:48Z","timestamp":1759759368000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10334-025-01241-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["1241"],"URL":"https:\/\/doi.org\/10.1007\/s10334-025-01241-7","relation":{},"ISSN":["1352-8661"],"issn-type":[{"type":"electronic","value":"1352-8661"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"14 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the animal experimental procedures were approved by the Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}